RNA interference

RNA interference is a conserved biological pathway in which small RNA molecules direct the sequence-specific silencing of gene expression. This process, fundamental to eukaryotic cell biology, plays critical roles in development, genome defense, and homeostasis. The discovery of this mechanism revolutionized molecular biology and has spawned significant applications in biotechnology and therapeutic development.

Discovery and history

The phenomenon was first observed in petunia plants during experiments aimed at deepening flower color, which unexpectedly led to gene silencing. Key foundational work in the nematode Caenorhabditis elegans by Andrew Fire and Craig Mello demonstrated that double-stranded RNA was the potent trigger, a discovery for which they were awarded the Nobel Prize in Physiology or Medicine in 2006. Earlier related observations included the discovery of cosuppression in plants and quelling in the fungus Neurospora crassa. Research at institutions like the Carnegie Institution for Science and the University of Massachusetts Medical School helped elucidate these early mysteries.

Mechanism of action

The core machinery involves the Dicer enzyme, which processes long double-stranded RNA into small interfering RNAs. These siRNAs are then loaded into the RNA-induced silencing complex, where the guide strand directs RISC to complementary messenger RNA sequences. Key catalytic components within RISC include proteins from the Argonaute family, such as Ago2 in humans, which cleave the target mRNA. This pathway shares mechanistic features with the endogenous microRNA pathway, which regulates normal cellular processes. The process can also lead to transcriptional silencing through interactions with chromatin and proteins like those in the Polycomb group.

Biological functions

It serves as a vital antiviral defense mechanism in plants, invertebrates, and some vertebrates, targeting viral RNA for degradation. In developmental biology, it is crucial for timing differentiation events and patterning, as extensively studied in C. elegans and Drosophila melanogaster. The pathway helps control the movement of transposable elements, preserving genome integrity. It also fine-tunes expression levels of proteins involved in metabolism and cellular stress responses, contributing to homeostasis.

Applications in research and medicine

It has become an indispensable tool in functional genomics, allowing systematic knockdown studies in model organisms like the zebrafish and mouse. In agriculture, it has been used to engineer crops, such as the Rainbow Papaya, resistant to the Papaya ringspot virus. Therapeutically, the first approved drug utilizing this principle, patisiran, treats hereditary transthyretin-mediated amyloidosis. Clinical trials are ongoing for conditions ranging from hypercholesterolemia, targeting PCSK9, to various cancers and hepatitis infections. Companies like Alnylam Pharmaceuticals and Ionis Pharmaceuticals are leaders in developing these oligonucleotide therapeutics.

Challenges and limitations

A major hurdle is the efficient and specific delivery of RNAi agents to target tissues in humans, avoiding rapid degradation by nucleases and clearance by the kidney. Off-target effects, where the RNAi machinery inadvertently silences genes with partial sequence homology, remain a significant safety concern. The immune system can mount an interferon response to certain RNA molecules, leading to potential toxicity. Furthermore, the high cost of manufacturing these complex therapeutics presents a barrier to widespread clinical adoption, challenging healthcare systems like the National Health Service.

Category:Molecular biology Category:Gene expression